首页 > 最新文献

Frontiers in Endocrinology最新文献

英文 中文
Triglyceride-glucose index is associated with heart failure with preserved ejection fraction in different metabolic states in patients with coronary heart disease. 甘油三酯-葡萄糖指数与冠心病患者不同代谢状态下射血分数保留型心力衰竭有关。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-04 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1447072
Zhu Li, Xiang Fan, Yijia Liu, Lu Yu, Yuanyuan He, Lin Li, Shan Gao, Wei Chen, Rongrong Yang, Chunquan Yu

Background: The triglyceride-glucose (TyG) index is a surrogate indicator of insulin resistance. Therefore, we aimed to determine the association between TyG index and heart failure (HF) with preserved ejection fraction (HFpEF) in patients with coronary heart disease (CHD) and to explore whether such associations would be modified by different metabolic states.

Methods: Among 107,301 CHD patients, 62,794 were included to analyze the relationship between the TyG index and HF. Among them, 8,606 patients who had undergone echocardiography were included to identify different types of HF, including HF with reduced ejection fraction (HFrEF), HF with intermediate-range ejection fraction (HFmrEF), and HFpEF. Among them, 1896 patients were diagnosed with HFpEF. Logistic regression was used to analyze the relationship between the TyG index and HFpEF in CHD patients. In addition, the association between TyG index and HFpEF according to sex, age, blood lipids, and blood pressure was assessed.

Results: A baseline analysis of CHD patients divided into four groups according to the tertile level of the TyG index showed significant differences in the related parameters between the groups. In the multi-adjusted models, the TyG index was significantly associated with the risk of HFpEF (odds ratio [OR]: 1.17; 95% confidence interval [CI]: 1.09-1.25). After adjustment for multivariates, TyG index levels for T2 (OR: 1.33; 95% CI: 1.16-1.52) and T3 (OR: 1.52; 95% CI: 1.32-1.74) were associated with increased OR in HFpEF. In addition, the TyG index of CHD patients was significantly associated with HFpEF in older adults aged > 60 years (OR: 1.20; 95% CI: 1.11-1.29), hypertension (OR: 1.27; 95% CI: 1.17-1.37), and dyslipidemia (OR: 1.15; 95% CI: 1.08-1.24). Moreover, the OR (OR: 1.23; 95% CI: 1.11-1.36) in women is higher than in men (OR: 1.17; 95% CI: 1.02-1.22, indicating a stronger association between TyG index and HFpEF in women.

Conclusions: Our findings demonstrated a significant association between TyG index and HFpEF in CHD patients. Furthermore, TyG index was independently associated with HFpEF in hypertension, dyslipidemia, and older patients (aged > 60 years). In addition, the association between the TyG index and HFpEF in CHD patients differed according to sex.

背景:甘油三酯-葡萄糖(TyG)指数是胰岛素抵抗的替代指标:甘油三酯-葡萄糖(TyG)指数是胰岛素抵抗的替代指标。因此,我们旨在确定TyG指数与冠心病患者射血分数保留型心力衰竭(HFpEF)之间的关系,并探讨这种关系是否会因不同的代谢状态而改变:在 107,301 名冠心病患者中,有 62,794 人被纳入分析 TyG 指数与 HF 之间的关系。其中,8606 名患者接受了超声心动图检查,以确定不同类型的心房颤动,包括射血分数减低型心房颤动(HFrEF)、射血分数中等型心房颤动(HFmrEF)和 HFpEF。其中,1896 名患者被诊断为 HFpEF。采用逻辑回归分析了TyG指数与心脏病患者HFpEF之间的关系。此外,还根据性别、年龄、血脂和血压评估了TyG指数与HFpEF之间的关系:结果:根据TyG指数的三等分水平将冠心病患者分为四组进行基线分析,结果显示各组之间的相关参数存在显著差异。在多重调整模型中,TyG指数与HFpEF风险显著相关(几率比[OR]:1.17;95%置信区间[CI]:1.09-1.25)。经多变量调整后,T2(OR:1.33;95% CI:1.16-1.52)和 T3(OR:1.52;95% CI:1.32-1.74)的 TyG 指数水平与 HFpEF 的 OR 增加相关。此外,CHD 患者的 TyG 指数与 60 岁以上老年人的 HFpEF(OR:1.20;95% CI:1.11-1.29)、高血压(OR:1.27;95% CI:1.17-1.37)和血脂异常(OR:1.15;95% CI:1.08-1.24)显著相关。此外,女性的OR值(OR:1.23;95% CI:1.11-1.36)高于男性(OR:1.17;95% CI:1.02-1.22),这表明女性TyG指数与HFpEF之间的关系更为密切:我们的研究结果表明,TyG指数与冠心病患者的高频低氧血症之间存在显著关联。此外,在高血压、血脂异常和老年患者(年龄大于 60 岁)中,TyG 指数与 HFpEF 呈独立相关。此外,不同性别的心脏病患者的TyG指数与HFpEF之间的关系也不尽相同。
{"title":"Triglyceride-glucose index is associated with heart failure with preserved ejection fraction in different metabolic states in patients with coronary heart disease.","authors":"Zhu Li, Xiang Fan, Yijia Liu, Lu Yu, Yuanyuan He, Lin Li, Shan Gao, Wei Chen, Rongrong Yang, Chunquan Yu","doi":"10.3389/fendo.2024.1447072","DOIUrl":"10.3389/fendo.2024.1447072","url":null,"abstract":"<p><strong>Background: </strong>The triglyceride-glucose (TyG) index is a surrogate indicator of insulin resistance. Therefore, we aimed to determine the association between TyG index and heart failure (HF) with preserved ejection fraction (HFpEF) in patients with coronary heart disease (CHD) and to explore whether such associations would be modified by different metabolic states.</p><p><strong>Methods: </strong>Among 107,301 CHD patients, 62,794 were included to analyze the relationship between the TyG index and HF. Among them, 8,606 patients who had undergone echocardiography were included to identify different types of HF, including HF with reduced ejection fraction (HFrEF), HF with intermediate-range ejection fraction (HFmrEF), and HFpEF. Among them, 1896 patients were diagnosed with HFpEF. Logistic regression was used to analyze the relationship between the TyG index and HFpEF in CHD patients. In addition, the association between TyG index and HFpEF according to sex, age, blood lipids, and blood pressure was assessed.</p><p><strong>Results: </strong>A baseline analysis of CHD patients divided into four groups according to the tertile level of the TyG index showed significant differences in the related parameters between the groups. In the multi-adjusted models, the TyG index was significantly associated with the risk of HFpEF (odds ratio [OR]: 1.17; 95% confidence interval [CI]: 1.09-1.25). After adjustment for multivariates, TyG index levels for T2 (OR: 1.33; 95% CI: 1.16-1.52) and T3 (OR: 1.52; 95% CI: 1.32-1.74) were associated with increased OR in HFpEF. In addition, the TyG index of CHD patients was significantly associated with HFpEF in older adults aged > 60 years (OR: 1.20; 95% CI: 1.11-1.29), hypertension (OR: 1.27; 95% CI: 1.17-1.37), and dyslipidemia (OR: 1.15; 95% CI: 1.08-1.24). Moreover, the OR (OR: 1.23; 95% CI: 1.11-1.36) in women is higher than in men (OR: 1.17; 95% CI: 1.02-1.22, indicating a stronger association between TyG index and HFpEF in women.</p><p><strong>Conclusions: </strong>Our findings demonstrated a significant association between TyG index and HFpEF in CHD patients. Furthermore, TyG index was independently associated with HFpEF in hypertension, dyslipidemia, and older patients (aged > 60 years). In addition, the association between the TyG index and HFpEF in CHD patients differed according to sex.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1447072"},"PeriodicalIF":3.9,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New insights into the role of cellular senescence and chronic wounds. 细胞衰老和慢性伤口作用的新见解。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-04 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1400462
Huiqing Yang, Xin Zhang, Bo Xue

Chronic or non-healing wounds, such as diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers (PUs) and wounds in the elderly etc., impose significant biological, social, and financial burdens on patients and their families. Despite ongoing efforts, effective treatments for these wounds remain elusive, costing the United States over US$25 billion annually. The wound healing process is notably slower in the elderly, partly due to cellular senescence, which plays a complex role in wound repair. High glucose levels, reactive oxygen species, and persistent inflammation are key factors that induce cellular senescence, contributing to chronic wound failure. This suggests that cellular senescence may not only drive age-related phenotypes and pathology but also be a key mediator of the decreased capacity for trauma repair. This review analyzes four aspects: characteristics of cellular senescence; cytotoxic stressors and related signaling pathways; the relationship between cellular senescence and typical chronic non-healing wounds; and current and future treatment strategies. In theory, anti-aging therapy may influence the process of chronic wound healing. However, the underlying molecular mechanism is not well understood. This review summarizes the relationship between cellular senescence and chronic wound healing to contribute to a better understanding of the mechanisms of chronic wound healing.

慢性或不愈合伤口,如糖尿病足溃疡 (DFU)、静脉腿部溃疡 (VLU)、压疮 (PU) 和老年人伤口等,给患者及其家庭带来了巨大的生理、社会和经济负担。尽管人们一直在努力,但这些伤口的有效治疗方法仍然遥遥无期,每年给美国造成的损失超过 250 亿美元。老年人的伤口愈合过程明显较慢,部分原因是细胞衰老,而细胞衰老在伤口修复中扮演着复杂的角色。高血糖、活性氧和持续炎症是诱导细胞衰老的关键因素,从而导致慢性伤口愈合失败。这表明,细胞衰老不仅可能驱动与年龄相关的表型和病理学,也可能是创伤修复能力下降的关键介质。本综述从四个方面进行了分析:细胞衰老的特征;细胞毒性应激源和相关信号通路;细胞衰老与典型慢性伤口不愈合之间的关系;以及当前和未来的治疗策略。从理论上讲,抗衰老疗法可能会影响慢性伤口愈合的过程。然而,人们对其潜在的分子机制还不甚了解。本综述总结了细胞衰老与慢性伤口愈合之间的关系,有助于更好地理解慢性伤口愈合的机制。
{"title":"New insights into the role of cellular senescence and chronic wounds.","authors":"Huiqing Yang, Xin Zhang, Bo Xue","doi":"10.3389/fendo.2024.1400462","DOIUrl":"10.3389/fendo.2024.1400462","url":null,"abstract":"<p><p>Chronic or non-healing wounds, such as diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers (PUs) and wounds in the elderly etc., impose significant biological, social, and financial burdens on patients and their families. Despite ongoing efforts, effective treatments for these wounds remain elusive, costing the United States over US$25 billion annually. The wound healing process is notably slower in the elderly, partly due to cellular senescence, which plays a complex role in wound repair. High glucose levels, reactive oxygen species, and persistent inflammation are key factors that induce cellular senescence, contributing to chronic wound failure. This suggests that cellular senescence may not only drive age-related phenotypes and pathology but also be a key mediator of the decreased capacity for trauma repair. This review analyzes four aspects: characteristics of cellular senescence; cytotoxic stressors and related signaling pathways; the relationship between cellular senescence and typical chronic non-healing wounds; and current and future treatment strategies. In theory, anti-aging therapy may influence the process of chronic wound healing. However, the underlying molecular mechanism is not well understood. This review summarizes the relationship between cellular senescence and chronic wound healing to contribute to a better understanding of the mechanisms of chronic wound healing.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1400462"},"PeriodicalIF":3.9,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The combination of metformin and high glucose increased longevity of Caenorhabditis elegans a DAF-16/FOXO-independent manner: cancer/diabetic model via C. elegans. 二甲双胍与高血糖的结合以 DAF-16/FOXO 非依赖性的方式延长了秀丽隐杆线虫的寿命:通过秀丽隐杆线虫建立癌症/糖尿病模型。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-04 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1435098
Şeyda Berk, Ali Cetin, Özgür Ülkü Özdemir, Ayşe Nur Pektaş, Nazan Yurtcu, Sevgi Durna Dastan

Introduction: Sedentary lifestyles and diets with high glycemic indexes are considered to be contributing factors to the development of obesity, type 2 diabetes in humans. Metformin, a biguanide medication commonly used to treat type 2 diabetes, has been observed to be associated with longevity; however, the molecular mechanisms underlying this observation are still unknown.

Methods: The effects of metformin and high glucose, which have important roles in aging-related disease such as diabetes and cancer, were studied in lin-35 worms because they are associated with cancer-associated pRb function in mammals and have a tumour suppressor property.

Results and discussion: According to our results, the negative effect of high glucose on egg production of lin-35 worms was greater than that of N2 worms. High glucose shortened lifespan and increased body length and width in individuals of both strains. Metformin treatment alone extended the lifespan of N2 and lin-35 worms by reducing fertilization efficiency. However, when metformin was administered in the presence of high glucose, the lifespan of lin-35 worms was clearly longer compared to N2 worms. Additionally, we conclude that glucose and metformin in lin35 worms can extend life expectancy through a DAF-16/FOXO-independent mechanism. Furthermore, the results of this study will provide a new perspective on extending mammalian lifespan through the model organism C. elegans.

导言:久坐不动的生活方式和高升糖指数饮食被认为是导致人类肥胖和 2 型糖尿病的因素。二甲双胍是一种常用于治疗 2 型糖尿病的双胍类药物,据观察,它与长寿有关;然而,这一观察结果的分子机制尚不清楚:方法:二甲双胍和高血糖在糖尿病和癌症等衰老相关疾病中具有重要作用,我们在 lin-35 蠕虫中研究了二甲双胍和高血糖的影响,因为它们在哺乳动物中与癌症相关的 pRb 功能有关,并具有肿瘤抑制特性:结果表明,高糖对 lin-35 蠕虫产卵量的负面影响大于 N2 蠕虫。高糖缩短了两个品系个体的寿命,增加了体长和体宽。单独使用二甲双胍可降低受精效率,从而延长N2和lin-35蠕虫的寿命。然而,当二甲双胍与高葡萄糖同时使用时,lin-35蠕虫的寿命明显长于N2蠕虫。此外,我们还得出结论,葡萄糖和二甲双胍可通过 DAF-16/FOXO 依赖性机制延长 lin35 蠕虫的寿命。此外,本研究的结果将为通过模式生物 elegans 延长哺乳动物寿命提供一个新的视角。
{"title":"The combination of metformin and high glucose increased longevity of <i>Caenorhabditis elegans</i> a DAF-16/FOXO-independent manner: cancer/diabetic model via <i>C. elegans</i>.","authors":"Şeyda Berk, Ali Cetin, Özgür Ülkü Özdemir, Ayşe Nur Pektaş, Nazan Yurtcu, Sevgi Durna Dastan","doi":"10.3389/fendo.2024.1435098","DOIUrl":"10.3389/fendo.2024.1435098","url":null,"abstract":"<p><strong>Introduction: </strong>Sedentary lifestyles and diets with high glycemic indexes are considered to be contributing factors to the development of obesity, type 2 diabetes in humans. Metformin, a biguanide medication commonly used to treat type 2 diabetes, has been observed to be associated with longevity; however, the molecular mechanisms underlying this observation are still unknown.</p><p><strong>Methods: </strong>The effects of metformin and high glucose, which have important roles in aging-related disease such as diabetes and cancer, were studied in lin-35 worms because they are associated with cancer-associated pRb function in mammals and have a tumour suppressor property.</p><p><strong>Results and discussion: </strong>According to our results, the negative effect of high glucose on egg production of lin-35 worms was greater than that of N2 worms. High glucose shortened lifespan and increased body length and width in individuals of both strains. Metformin treatment alone extended the lifespan of N2 and lin-35 worms by reducing fertilization efficiency. However, when metformin was administered in the presence of high glucose, the lifespan of lin-35 worms was clearly longer compared to N2 worms. Additionally, we conclude that glucose and metformin in lin35 worms can extend life expectancy through a DAF-16/FOXO-independent mechanism. Furthermore, the results of this study will provide a new perspective on extending mammalian lifespan through the model organism <i>C. elegans</i>.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1435098"},"PeriodicalIF":3.9,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aldosterone in the brain and cognition: knowns and unknowns. 大脑和认知中的醛固酮:已知与未知。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-01 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1456211
Anna Nieckarz, Beata Graff, Michel Burnier, Anna B Marcinkowska, Krzysztof Narkiewicz

Mineralocorticoid receptors are expressed in several structures of the central nervous system, and aldosterone levels can be measured in the brain, although in smaller amounts than in plasma. Nevertheless, these amounts appear to be sufficient to elicit substantial clinical effects. Primary aldosteronism, characterized by high levels of plasma aldosterone, is one of the most common causes of secondary hypertension. In this context, high aldosterone levels may have both indirect and direct effects on the brain with a negative impact on several cerebral functions. Thus, chronic aldosterone excess has been associated with symptoms of anxiety and depression - two clinical entities themselves associated with cognitive deficits. Today, there is an increasing number of reports on the influence of aldosterone on the brain, but there is also a significant amount of uncertainty, such as the role of high aldosterone levels on cognitive functions and decline independently of blood pressure. In this mini review, we discuss the known and unknowns of the impact of aldosterone on the brain putting emphasis on cognitive functions.

矿物皮质激素受体在中枢神经系统的多个结构中都有表达,醛固酮水平可在大脑中测得,但其含量低于血浆。尽管如此,这些量似乎足以引起实质性的临床效应。原发性醛固酮增多症的特点是血浆中醛固酮水平较高,是继发性高血压最常见的原因之一。在这种情况下,高水平的醛固酮可能会对大脑产生间接和直接的影响,对多种大脑功能产生负面影响。因此,长期醛固酮过多与焦虑和抑郁症状有关,而这两种临床症状本身就与认知障碍有关。如今,有关醛固酮对大脑影响的报道越来越多,但也存在大量不确定性,例如高水平醛固酮对认知功能的作用以及与血压无关的认知功能衰退。在这篇微型综述中,我们将讨论醛固酮对大脑影响的已知和未知因素,重点是认知功能。
{"title":"Aldosterone in the brain and cognition: knowns and unknowns.","authors":"Anna Nieckarz, Beata Graff, Michel Burnier, Anna B Marcinkowska, Krzysztof Narkiewicz","doi":"10.3389/fendo.2024.1456211","DOIUrl":"10.3389/fendo.2024.1456211","url":null,"abstract":"<p><p>Mineralocorticoid receptors are expressed in several structures of the central nervous system, and aldosterone levels can be measured in the brain, although in smaller amounts than in plasma. Nevertheless, these amounts appear to be sufficient to elicit substantial clinical effects. Primary aldosteronism, characterized by high levels of plasma aldosterone, is one of the most common causes of secondary hypertension. In this context, high aldosterone levels may have both indirect and direct effects on the brain with a negative impact on several cerebral functions. Thus, chronic aldosterone excess has been associated with symptoms of anxiety and depression - two clinical entities themselves associated with cognitive deficits. Today, there is an increasing number of reports on the influence of aldosterone on the brain, but there is also a significant amount of uncertainty, such as the role of high aldosterone levels on cognitive functions and decline independently of blood pressure. In this mini review, we discuss the known and unknowns of the impact of aldosterone on the brain putting emphasis on cognitive functions.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1456211"},"PeriodicalIF":3.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of probiotic supplementation on bone health in postmenopausal women: a systematic review and meta-analysis. 补充益生菌对绝经后妇女骨骼健康的影响:系统综述和荟萃分析。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-01 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1487998
Fang Wang, Wei Wei, Peng Ju Liu

Context: The beneficial effects of probiotic supplementation on bone health in postmenopausal women require further validation.

Objective: This study systematically reviewed and conducted a meta-analysis of randomized controlled trials (RCTs) to assess the relationship between probiotic supplementation and changes in bone mineral density (BMD) and bone turnover markers (BTMs) among postmenopausal women.

Methods: A systematic search was conducted across four databases to retrieve data on lumbar spine BMD, hip BMD, collagen type 1 cross-linked C-telopeptide (CTX), receptor activator of nuclear factor-κB ligand (RANKL), osteocalcin (OC), osteoprotegerin (OPG), N-terminal propeptide of type 1 procollagen (P1NP), and bone-specific alkaline phosphatase (BALP) in postmenopausal women. Eligible RCTs were quantitatively analyzed using random-effects meta-analyses. Additional analyses, including subgroup, sensitivity, and meta-regression analyses, were performed.

Results: Twelve RCTs involving 1183 postmenopausal women were included. Compared with the control group, postmenopausal women who received probiotic supplementation showed significantly greater BMD in both the lumbar spine (standardized mean difference [SMD] = 0.60, 95% confidence interval [CI] 0.14 to 1.05) and the hip (SMD = 0.74, 95%CI 0.15 to 1.33). Additionally, probiotic supplementation was associated with reduced levels of CTX (SMD = -1.51, 95%CI -1.88 to -0.41) and BALP (SMD = -1.80, 95%CI -2.78 to -0.81). No significant differences were found between the probiotic and control groups in terms of other BTMs. Subgroup analyses revealed that the increase in BMD due to probiotic supplementation was more significant in postmenopausal women with osteopenia than in those with osteoporosis. The meta-analysis results for both lumbar spine and hip BMD remained robust after conducting sensitivity analyses and meta-regressions.

Conclusion: Supplementation with probiotics may increase BMD among postmenopausal women, with stronger evidence in women with osteopenia than osteoporosis. Further RCTs are suggested to confirm and refine these findings.

Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024576764.

背景:补充益生菌对绝经后妇女骨骼健康的有益影响需要进一步验证:本研究对随机对照试验(RCTs)进行了系统回顾和荟萃分析,以评估绝经后妇女补充益生菌与骨矿物质密度(BMD)和骨转换标志物(BTMs)变化之间的关系:在四个数据库中进行了系统搜索,以检索绝经后妇女腰椎骨矿物质密度、髋骨矿物质密度、1型胶原交联C-肽(CTX)、核因子-κB配体受体激活剂(RANKL)、骨钙素(OC)、骨保护蛋白(OPG)、1型胶原蛋白N端前肽(P1NP)和骨特异性碱性磷酸酶(BALP)的数据。采用随机效应荟萃分析法对符合条件的 RCT 进行了定量分析。还进行了其他分析,包括亚组分析、敏感性分析和元回归分析:结果:共纳入了 12 项研究,涉及 1183 名绝经后妇女。与对照组相比,接受益生菌补充剂的绝经后妇女腰椎(标准化平均差 [SMD] = 0.60,95% 置信区间 [CI] 0.14 至 1.05)和髋部(SMD = 0.74,95%CI 0.15 至 1.33)的 BMD 均显著增加。此外,补充益生菌与 CTX(SMD =-1.51,95%CI -1.88至-0.41)和 BALP(SMD =-1.80,95%CI -2.78至-0.81)水平的降低有关。益生菌组和对照组在其他 BTM 方面没有发现明显差异。亚组分析显示,补充益生菌对绝经后妇女骨质疏松症患者的骨密度增加比对骨质疏松症患者的增加更为显著。在进行了敏感性分析和元回归后,腰椎和髋部 BMD 的元分析结果仍然保持稳定:结论:补充益生菌可增加绝经后妇女的 BMD,在骨质疏松症妇女中的证据比在骨质疏松症妇女中的证据更充分。建议进一步开展 RCT 研究,以证实和完善这些发现。系统综述注册:https://www.crd.york.ac.uk/PROSPERO/,标识符为 CRD42024576764。
{"title":"Effects of probiotic supplementation on bone health in postmenopausal women: a systematic review and meta-analysis.","authors":"Fang Wang, Wei Wei, Peng Ju Liu","doi":"10.3389/fendo.2024.1487998","DOIUrl":"10.3389/fendo.2024.1487998","url":null,"abstract":"<p><strong>Context: </strong>The beneficial effects of probiotic supplementation on bone health in postmenopausal women require further validation.</p><p><strong>Objective: </strong>This study systematically reviewed and conducted a meta-analysis of randomized controlled trials (RCTs) to assess the relationship between probiotic supplementation and changes in bone mineral density (BMD) and bone turnover markers (BTMs) among postmenopausal women.</p><p><strong>Methods: </strong>A systematic search was conducted across four databases to retrieve data on lumbar spine BMD, hip BMD, collagen type 1 cross-linked C-telopeptide (CTX), receptor activator of nuclear factor-κB ligand (RANKL), osteocalcin (OC), osteoprotegerin (OPG), N-terminal propeptide of type 1 procollagen (P1NP), and bone-specific alkaline phosphatase (BALP) in postmenopausal women. Eligible RCTs were quantitatively analyzed using random-effects meta-analyses. Additional analyses, including subgroup, sensitivity, and meta-regression analyses, were performed.</p><p><strong>Results: </strong>Twelve RCTs involving 1183 postmenopausal women were included. Compared with the control group, postmenopausal women who received probiotic supplementation showed significantly greater BMD in both the lumbar spine (standardized mean difference [SMD] = 0.60, 95% confidence interval [CI] 0.14 to 1.05) and the hip (SMD = 0.74, 95%CI 0.15 to 1.33). Additionally, probiotic supplementation was associated with reduced levels of CTX (SMD = -1.51, 95%CI -1.88 to -0.41) and BALP (SMD = -1.80, 95%CI -2.78 to -0.81). No significant differences were found between the probiotic and control groups in terms of other BTMs. Subgroup analyses revealed that the increase in BMD due to probiotic supplementation was more significant in postmenopausal women with osteopenia than in those with osteoporosis. The meta-analysis results for both lumbar spine and hip BMD remained robust after conducting sensitivity analyses and meta-regressions.</p><p><strong>Conclusion: </strong>Supplementation with probiotics may increase BMD among postmenopausal women, with stronger evidence in women with osteopenia than osteoporosis. Further RCTs are suggested to confirm and refine these findings.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024576764.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1487998"},"PeriodicalIF":3.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563942/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new LNC89/LNC60-Col11a2 axis revealed by whole-transcriptome analysis may be associated with goiters related to excess iodine nutrition. 通过全转录组分析发现的一个新的 LNC89/LNC60-Col11a2 轴可能与碘营养过剩引起的甲状腺肿有关。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1407859
Guanying Nie, Shuang Li, Wei Zhang, Fangang Meng, Zixuan Ru, Jiahui Li, Dianjun Sun, Ming Li

Goiter related to excessive iodine nutrition remains a significant public health issue in some countries. There has been no reported study on long noncoding RNAs (lncRNAs) related to goiters. In this study, goiter was induced by drinking water with excess iodine for 10 or 20 weeks in Kunming mice. Whole transcriptome sequencing results showed that LNC89 expression increased in mice goiter tissues compared to normal thyroid tissues and higher in 20 weeks goiter tissues than in 10 weeks goiter tissues, which were identified by qRT-PCR. Cooperate with human-mouse homologous gene conversion, a new LNC89/LNC60-Col11a2 axis was predicted by LncTar and expression correlation analysis based on whole transcriptome sequencing results. Increased Col11a2 expression was also identified by qRT-PCR and Western blot in the mice goiter tissues. In the human normal thyroid cell line Nthy-ori-3 treated with KI03, LNC60 and Col11a2 expression increased with promoted cell viability, which were reversed by siLNC60 treatment. Furthermore, LNC60 and Col11a2 mRNA levels were found increased in peripheral blood of nodular goiter patients from high water iodine areas of China and have high diagnostic values for nodular goiter while AUC of LNC60 and Col11a2 are 89.97% and 84.85%, respectively. In conclusion, the novel LNC89/LNC60-Col11a2 axis may be involved in the progression of goiter related to iodine excess, providing potential biomarkers and therapeutic targets in the future.

在一些国家,与碘营养过剩有关的甲状腺肿仍然是一个重要的公共卫生问题。目前还没有关于与甲状腺肿有关的长非编码RNA(lncRNA)的研究报道。本研究通过饮用碘过量的水诱导昆明小鼠患甲状腺肿10周或20周。全转录组测序结果显示,与正常甲状腺组织相比,小鼠甲状腺肿组织中LNC89的表达量增加,且20周甲状腺肿组织中LNC89的表达量高于10周甲状腺肿组织。在人鼠同源基因转换的作用下,根据全转录组测序结果,通过 LncTar 和表达相关性分析预测了一个新的 LNC89/LNC60-Col11a2 轴。在小鼠甲状腺肿组织中,通过 qRT-PCR 和 Western 印迹也发现了 Col11a2 表达的增加。在用 KI03 处理的人类正常甲状腺细胞系 Nthy-orii-3 中,LNC60 和 Col11a2 表达增加,细胞活力提高,而 siLNC60 处理可逆转这种情况。此外,在中国高水碘地区的结节性甲状腺肿患者外周血中发现 LNC60 和 Col11a2 mRNA 水平升高,对结节性甲状腺肿有较高的诊断价值,而 LNC60 和 Col11a2 的 AUC 分别为 89.97% 和 84.85%。总之,新的LNC89/LNC60-Col11a2轴可能参与了与碘过量有关的甲状腺肿的进展,为未来提供了潜在的生物标志物和治疗靶点。
{"title":"A new LNC89/LNC60-Col11a2 axis revealed by whole-transcriptome analysis may be associated with goiters related to excess iodine nutrition.","authors":"Guanying Nie, Shuang Li, Wei Zhang, Fangang Meng, Zixuan Ru, Jiahui Li, Dianjun Sun, Ming Li","doi":"10.3389/fendo.2024.1407859","DOIUrl":"10.3389/fendo.2024.1407859","url":null,"abstract":"<p><p>Goiter related to excessive iodine nutrition remains a significant public health issue in some countries. There has been no reported study on long noncoding RNAs (lncRNAs) related to goiters. In this study, goiter was induced by drinking water with excess iodine for 10 or 20 weeks in Kunming mice. Whole transcriptome sequencing results showed that LNC89 expression increased in mice goiter tissues compared to normal thyroid tissues and higher in 20 weeks goiter tissues than in 10 weeks goiter tissues, which were identified by qRT-PCR. Cooperate with human-mouse homologous gene conversion, a new LNC89/LNC60-Col11a2 axis was predicted by LncTar and expression correlation analysis based on whole transcriptome sequencing results. Increased Col11a2 expression was also identified by qRT-PCR and Western blot in the mice goiter tissues. In the human normal thyroid cell line Nthy-ori-3 treated with KI0<sub>3</sub>, LNC60 and Col11a2 expression increased with promoted cell viability, which were reversed by siLNC60 treatment. Furthermore, LNC60 and Col11a2 mRNA levels were found increased in peripheral blood of nodular goiter patients from high water iodine areas of China and have high diagnostic values for nodular goiter while AUC of LNC60 and Col11a2 are 89.97% and 84.85%, respectively. In conclusion, the novel LNC89/LNC60-Col11a2 axis may be involved in the progression of goiter related to iodine excess, providing potential biomarkers and therapeutic targets in the future.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1407859"},"PeriodicalIF":3.9,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570895/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between systemic immune-inflammatory index and systemic inflammatory response index with body mass index in children and adolescents: a population-based study based on the National Health and Nutrition Examination Survey 2017-2020. 儿童和青少年全身免疫炎症指数和全身炎症反应指数与体重指数之间的关系:基于 2017-2020 年全国健康与营养调查的一项人群研究。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1426404
Lisha Luo, Lin Chen, Jukun Song, Xiuqi Ma, Xike Wang

Background: The Systemic Immune-Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI) are novel composite inflammatory markers. Previous studies suggest that obesity in individuals correlates with persistently low levels of chronic inflammation. This study aims to explore the association between SII and SIRI and Body Mass Index (BMI) among children and adolescents.

Methods: A cross-sectional survey was conducted using the National Health and Nutrition Examination Survey (NHANES) dataset from 2 consecutive cycles from 2017-2020. Multivariate linear regression models were employed to examine the linear relationships between BMI and SII and SIRI. Non-linear associations were explored using smooth curve fitting and threshold effect analysis.

Results: A total of 2980 children and adolescents aged 6-19 years were included in this population-based study. In the population description of body mass index categories, we found progressively higher levels of SII and SIRI, notably peaking among obese children (SII mean ± SD: 528.83 ± 285.46; SIRI mean ± SD: 1.12 ± 0.79). Weighted multivariate linear regression confirmed a significant positive association between BMI and both inflammatory indices (P < 0.0001). Subgroup analyses revealed consistent correlations across gender divisions and highlighted a non-linear relationship between BMI and SII.

Conclusions: SII and SIRI are positively associated with BMI in children and adolescents, indicating their potential as markers for assessing systemic inflammation in pediatric obesity. Further large-scale prospective studies are required to substantiate these findings.

背景:系统免疫炎症指数(SII)和系统炎症反应指数(SIRI)是新型的复合炎症指标。以往的研究表明,肥胖者的慢性炎症水平持续较低。本研究旨在探讨 SII 和 SIRI 与儿童和青少年体重指数(BMI)之间的关联:采用美国国家健康与营养调查(NHANES)2017-2020年连续2个周期的数据集进行横断面调查。采用多变量线性回归模型来检验 BMI 与 SII 和 SIRI 之间的线性关系。利用平滑曲线拟合和阈值效应分析探讨了非线性关联:这项以人口为基础的研究共纳入了 2980 名 6-19 岁的儿童和青少年。在按体重指数分类的人群描述中,我们发现 SII 和 SIRI 的水平逐渐升高,肥胖儿童的水平达到峰值(SII 平均值 ± SD:528.83 ± 285.46;SIRI 平均值 ± SD:1.12 ± 0.79)。加权多变量线性回归证实,体重指数与两个炎症指数之间存在显著的正相关(P < 0.0001)。分组分析表明,不同性别之间存在一致的相关性,并强调了体重指数与 SII 之间的非线性关系:结论:SII 和 SIRI 与儿童和青少年的体重指数呈正相关,表明它们有可能成为评估小儿肥胖症全身炎症的标志物。需要进一步开展大规模的前瞻性研究来证实这些发现。
{"title":"Association between systemic immune-inflammatory index and systemic inflammatory response index with body mass index in children and adolescents: a population-based study based on the National Health and Nutrition Examination Survey 2017-2020.","authors":"Lisha Luo, Lin Chen, Jukun Song, Xiuqi Ma, Xike Wang","doi":"10.3389/fendo.2024.1426404","DOIUrl":"10.3389/fendo.2024.1426404","url":null,"abstract":"<p><strong>Background: </strong>The Systemic Immune-Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI) are novel composite inflammatory markers. Previous studies suggest that obesity in individuals correlates with persistently low levels of chronic inflammation. This study aims to explore the association between SII and SIRI and Body Mass Index (BMI) among children and adolescents.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted using the National Health and Nutrition Examination Survey (NHANES) dataset from 2 consecutive cycles from 2017-2020. Multivariate linear regression models were employed to examine the linear relationships between BMI and SII and SIRI. Non-linear associations were explored using smooth curve fitting and threshold effect analysis.</p><p><strong>Results: </strong>A total of 2980 children and adolescents aged 6-19 years were included in this population-based study. In the population description of body mass index categories, we found progressively higher levels of SII and SIRI, notably peaking among obese children (SII mean ± SD: 528.83 ± 285.46; SIRI mean ± SD: 1.12 ± 0.79). Weighted multivariate linear regression confirmed a significant positive association between BMI and both inflammatory indices (<i>P</i> < 0.0001). Subgroup analyses revealed consistent correlations across gender divisions and highlighted a non-linear relationship between BMI and SII.</p><p><strong>Conclusions: </strong>SII and SIRI are positively associated with BMI in children and adolescents, indicating their potential as markers for assessing systemic inflammation in pediatric obesity. Further large-scale prospective studies are required to substantiate these findings.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1426404"},"PeriodicalIF":3.9,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identify novel therapeutic targets for type II diabetes and periodontitis: insights from single-cell analysis and Mendelian randomization analysis. 确定 II 型糖尿病和牙周炎的新治疗靶点:单细胞分析和孟德尔随机分析的启示。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1410537
Mingrui Zou, Jichun Yang
<p><strong>Background: </strong>Periodontitis is a common complication of type II diabetes (T2D). However, the existing research cannot fully elucidate the association between them, let alone identify therapeutic targets for precise treatment of diabetic periodontitis. Therefore, we employed integrated genetic approaches such as single-cell analysis, Mendelian randomization (MR) analysis and colocalization analysis to uncover novel therapeutic targets for T2D and periodontitis.</p><p><strong>Methods: </strong>This study integrated single-cell analysis, MR analysis, colocalization analysis, phenotype scanning, cell-cell communication analysis and metabolic pathway activity analysis to unveil novel therapeutic targets for periodontitis and T2D. We firstly identified core cell clusters of T2D and periodontitis, and important marker genes were selected. The causal associations between these genes and the two diseases were evaluated through MR analysis. Reverse MR analysis, colocalization analysis, additional validation and phenotype scanning further supported our findings. Finally, cell-cell communication analysis and metabolic pathway activity analysis were employed to preliminarily investigate the mechanisms of the observed causal associations.</p><p><strong>Results: </strong>Through analysis of scRNA-seq data, we identified classical monocytes and intermediate monocytes as core cell subclusters. Differential analysis identified 221 differentially expressed genes (DEGs). MR analysis identified 13 genes exhibiting causal associations with T2D, and 11 causal genes with periodontitis. Colocalization analysis, reverse MR analysis, additional validation and phenotype scanning further enhanced the robustness of our results. Finally, we identified NCF1 as the core therapeutic target for T2D (OR = 1.09, 95% CI: 1.03-1.14, <i>p</i> = 1.85 <math><mrow><mo> </mo> <mo>×</mo> <msup><mrow><mn>10</mn></mrow> <mrow><mo>-</mo> <mn>3</mn></mrow> </msup> </mrow> </math> ) and LRRC25 for T2D (OR = 0.96, 95% CI: 0.93-0.99, <i>p</i> = 3.44 <math><mrow><mo> </mo> <mo>×</mo> <msup><mrow><mn>10</mn></mrow> <mrow><mo>-</mo> <mn>2</mn></mrow> </msup> </mrow> </math> ) and periodontitis (OR = 0.92, 95% CI: 0.84-0.99, <i>p</i> = 4.45 <math><mrow><mo> </mo> <mo>×</mo> <msup><mrow><mn>10</mn></mrow> <mrow><mo>-</mo> <mn>2</mn></mrow> </msup> </mrow> </math> ). At last, cell-cell communication analysis indicated significant differences in functions and metabolic pathway activity between monocytes expressing or not expressing the core causal genes, which preliminarily interpreted the observed causal associations.</p><p><strong>Conclusion: </strong>This study integrated single-cell analysis, MR analysis and colocalization analysis to identified novel therapeutic targets for T2D and periodontitis. 13 causal genes were identified for T2D, and 11 for periodontitis. Among them, NCF1 and LRRC25 were regarded as core therapeutic targets. Our findings bridge the gap in the understanding o
背景:牙周炎是 II 型糖尿病(T2D)的常见并发症:牙周炎是 II 型糖尿病(T2D)的常见并发症。然而,现有的研究还不能完全阐明它们之间的关联,更不用说确定精确治疗糖尿病牙周炎的靶点了。因此,我们采用了单细胞分析、孟德尔随机化(MR)分析和共定位分析等综合遗传学方法来发现治疗 T2D 和牙周炎的新靶点:本研究整合了单细胞分析、孟德尔随机化分析、共聚焦分析、表型扫描、细胞间通讯分析和代谢通路活性分析,以揭示牙周炎和 T2D 的新型治疗靶点。我们首先确定了 T2D 和牙周炎的核心细胞群,并筛选出了重要的标记基因。通过磁共振分析评估了这些基因与这两种疾病之间的因果关系。反向磁共振分析、共定位分析、附加验证和表型扫描进一步支持了我们的发现。最后,我们采用了细胞-细胞通讯分析和代谢通路活性分析来初步研究观察到的因果关系的机制:通过分析 scRNA-seq 数据,我们发现经典单核细胞和中间单核细胞是核心细胞亚群。差异分析确定了 221 个差异表达基因(DEGs)。MR分析发现了13个与T2D有因果关系的基因,以及11个与牙周炎有因果关系的基因。共定位分析、反向磁共振分析、附加验证和表型扫描进一步增强了我们结果的稳健性。最后,我们发现 NCF1 是治疗 T2D 的核心靶点(OR = 1.09,95% CI:1.03-1.14,p = 1.85 × 10 - 3),LRRC25 是治疗 T2D(OR = 0.96,95% CI:0.93-0.99,p = 3.44 × 10 - 2)和牙周炎(OR = 0.92,95% CI:0.84-0.99,p = 4.45 × 10 - 2)的核心靶点。最后,细胞间通讯分析表明,表达或不表达核心致病基因的单核细胞在功能和代谢途径活性上存在显著差异,这初步解释了观察到的因果关系:本研究综合了单细胞分析、磁共振分析和共定位分析,确定了治疗 T2D 和牙周炎的新靶点。研究发现了 13 个与 T2D 相关的因果基因,11 个与牙周炎相关。其中,NCF1和LRRC25被认为是核心治疗靶点。我们的发现弥补了人们对 T2D 和牙周炎之间关联性认识的不足,为这两种疾病的靶向治疗铺平了道路。
{"title":"Identify novel therapeutic targets for type II diabetes and periodontitis: insights from single-cell analysis and Mendelian randomization analysis.","authors":"Mingrui Zou, Jichun Yang","doi":"10.3389/fendo.2024.1410537","DOIUrl":"10.3389/fendo.2024.1410537","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Periodontitis is a common complication of type II diabetes (T2D). However, the existing research cannot fully elucidate the association between them, let alone identify therapeutic targets for precise treatment of diabetic periodontitis. Therefore, we employed integrated genetic approaches such as single-cell analysis, Mendelian randomization (MR) analysis and colocalization analysis to uncover novel therapeutic targets for T2D and periodontitis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This study integrated single-cell analysis, MR analysis, colocalization analysis, phenotype scanning, cell-cell communication analysis and metabolic pathway activity analysis to unveil novel therapeutic targets for periodontitis and T2D. We firstly identified core cell clusters of T2D and periodontitis, and important marker genes were selected. The causal associations between these genes and the two diseases were evaluated through MR analysis. Reverse MR analysis, colocalization analysis, additional validation and phenotype scanning further supported our findings. Finally, cell-cell communication analysis and metabolic pathway activity analysis were employed to preliminarily investigate the mechanisms of the observed causal associations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Through analysis of scRNA-seq data, we identified classical monocytes and intermediate monocytes as core cell subclusters. Differential analysis identified 221 differentially expressed genes (DEGs). MR analysis identified 13 genes exhibiting causal associations with T2D, and 11 causal genes with periodontitis. Colocalization analysis, reverse MR analysis, additional validation and phenotype scanning further enhanced the robustness of our results. Finally, we identified NCF1 as the core therapeutic target for T2D (OR = 1.09, 95% CI: 1.03-1.14, &lt;i&gt;p&lt;/i&gt; = 1.85 &lt;math&gt;&lt;mrow&gt;&lt;mo&gt; &lt;/mo&gt; &lt;mo&gt;×&lt;/mo&gt; &lt;msup&gt;&lt;mrow&gt;&lt;mn&gt;10&lt;/mn&gt;&lt;/mrow&gt; &lt;mrow&gt;&lt;mo&gt;-&lt;/mo&gt; &lt;mn&gt;3&lt;/mn&gt;&lt;/mrow&gt; &lt;/msup&gt; &lt;/mrow&gt; &lt;/math&gt; ) and LRRC25 for T2D (OR = 0.96, 95% CI: 0.93-0.99, &lt;i&gt;p&lt;/i&gt; = 3.44 &lt;math&gt;&lt;mrow&gt;&lt;mo&gt; &lt;/mo&gt; &lt;mo&gt;×&lt;/mo&gt; &lt;msup&gt;&lt;mrow&gt;&lt;mn&gt;10&lt;/mn&gt;&lt;/mrow&gt; &lt;mrow&gt;&lt;mo&gt;-&lt;/mo&gt; &lt;mn&gt;2&lt;/mn&gt;&lt;/mrow&gt; &lt;/msup&gt; &lt;/mrow&gt; &lt;/math&gt; ) and periodontitis (OR = 0.92, 95% CI: 0.84-0.99, &lt;i&gt;p&lt;/i&gt; = 4.45 &lt;math&gt;&lt;mrow&gt;&lt;mo&gt; &lt;/mo&gt; &lt;mo&gt;×&lt;/mo&gt; &lt;msup&gt;&lt;mrow&gt;&lt;mn&gt;10&lt;/mn&gt;&lt;/mrow&gt; &lt;mrow&gt;&lt;mo&gt;-&lt;/mo&gt; &lt;mn&gt;2&lt;/mn&gt;&lt;/mrow&gt; &lt;/msup&gt; &lt;/mrow&gt; &lt;/math&gt; ). At last, cell-cell communication analysis indicated significant differences in functions and metabolic pathway activity between monocytes expressing or not expressing the core causal genes, which preliminarily interpreted the observed causal associations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This study integrated single-cell analysis, MR analysis and colocalization analysis to identified novel therapeutic targets for T2D and periodontitis. 13 causal genes were identified for T2D, and 11 for periodontitis. Among them, NCF1 and LRRC25 were regarded as core therapeutic targets. Our findings bridge the gap in the understanding o","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1410537"},"PeriodicalIF":3.9,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endocrine disorders in Rett syndrome: a systematic review of the literature. 雷特综合征的内分泌紊乱:文献系统回顾。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1477227
Giorgia Pepe, Roberto Coco, Domenico Corica, Giovanni Luppino, Letteria Anna Morabito, Cecilia Lugarà, Tiziana Abbate, Giuseppina Zirilli, Tommaso Aversa, Stefano Stagi, Malgorzata Wasniewska

Background: Rett syndrome (RTT) is an X-linked progressive neurodevelopmental disorder that involves mainly girls and is the second most frequent cause of genetic intellectual disability. RTT leads to neurological regression between 6 and 18 months of life and could be associated with a variable neurological impairment. However, RTT affects not only neurological function but also wide aspects of non-neurological organs. Recent data showed that the endocrine system is often involved in RTT patients, including disorders of growth, bone health, thyroid, puberty onset, and weight abnormalities However, systematic data on endocrinopathies in RTT are scarce and limited.

Objective: This review aims to analyze the prevalence and type of endocrine comorbidities in RTT population, to allow a precocious diagnosis and appropriate endocrinological management.

Methods: Systematic research was carried out from January 2000 to March 2024 through MEDLINE via PubMed, Scopus, and the Cochrane Library.

Results: After the selection phase, a total of 22 studies (1090 screened) met the inclusion criteria and were reported in the present review. Five studies were observational-retrospective, four were cross-sectional and case report or series, three were survey, prospective, and case-control, and finally one study for descriptive-transversal and longitudinal population-based study. The sample population consisted of multiethnic groups or single ethnic groups. The main endocrinopathies reported were malnutrition, bone alterations, and alterations of puberty onset.

Conclusions: Our analysis shows that endocrinopathies are not rare in RTT patients. Therefore, in the context of a multidisciplinary approach, accurate screening and monitoring for endocrinopathies should be recommended in all RTT patients, to improve clinical practice, healthcare management, and, finally, patients' quality of life.

背景介绍雷特综合征(RTT)是一种 X 连锁进行性神经发育障碍,主要累及女孩,是遗传性智障的第二大常见病因。RTT 会导致患者在出生后 6 到 18 个月内出现神经系统退化,并可能伴有不同程度的神经系统损伤。然而,RTT 不仅会影响神经功能,还会影响非神经器官的多个方面。最近的数据显示,RTT 患者的内分泌系统经常受到影响,包括发育障碍、骨骼健康、甲状腺、青春期开始和体重异常等:本综述旨在分析RTT人群中内分泌合并症的发病率和类型,以便及早诊断并进行适当的内分泌治疗:2000年1月至2024年3月期间,通过PubMed、Scopus和Cochrane图书馆的MEDLINE进行了系统研究:经过筛选,共有 22 项研究(共筛选出 1090 项)符合纳入标准,并在本综述中进行了报告。其中 5 项研究为观察性-回顾性研究,4 项为横断面和病例报告或系列研究,3 项为调查性、前瞻性和病例对照研究,最后 1 项为描述性-横向和纵向人群研究。样本人群包括多民族群体或单一民族群体。报告的主要内分泌疾病是营养不良、骨骼改变和青春期发育改变:我们的分析表明,内分泌疾病在 RTT 患者中并不罕见。因此,在多学科方法的背景下,应建议对所有 RTT 患者进行准确的内分泌疾病筛查和监测,以改善临床实践和医疗管理,最终提高患者的生活质量。
{"title":"Endocrine disorders in Rett syndrome: a systematic review of the literature.","authors":"Giorgia Pepe, Roberto Coco, Domenico Corica, Giovanni Luppino, Letteria Anna Morabito, Cecilia Lugarà, Tiziana Abbate, Giuseppina Zirilli, Tommaso Aversa, Stefano Stagi, Malgorzata Wasniewska","doi":"10.3389/fendo.2024.1477227","DOIUrl":"10.3389/fendo.2024.1477227","url":null,"abstract":"<p><strong>Background: </strong>Rett syndrome (RTT) is an X-linked progressive neurodevelopmental disorder that involves mainly girls and is the second most frequent cause of genetic intellectual disability. RTT leads to neurological regression between 6 and 18 months of life and could be associated with a variable neurological impairment. However, RTT affects not only neurological function but also wide aspects of non-neurological organs. Recent data showed that the endocrine system is often involved in RTT patients, including disorders of growth, bone health, thyroid, puberty onset, and weight abnormalities However, systematic data on endocrinopathies in RTT are scarce and limited.</p><p><strong>Objective: </strong>This review aims to analyze the prevalence and type of endocrine comorbidities in RTT population, to allow a precocious diagnosis and appropriate endocrinological management.</p><p><strong>Methods: </strong>Systematic research was carried out from January 2000 to March 2024 through MEDLINE via PubMed, Scopus, and the Cochrane Library.</p><p><strong>Results: </strong>After the selection phase, a total of 22 studies (1090 screened) met the inclusion criteria and were reported in the present review. Five studies were observational-retrospective, four were cross-sectional and case report or series, three were survey, prospective, and case-control, and finally one study for descriptive-transversal and longitudinal population-based study. The sample population consisted of multiethnic groups or single ethnic groups. The main endocrinopathies reported were malnutrition, bone alterations, and alterations of puberty onset.</p><p><strong>Conclusions: </strong>Our analysis shows that endocrinopathies are not rare in RTT patients. Therefore, in the context of a multidisciplinary approach, accurate screening and monitoring for endocrinopathies should be recommended in all RTT patients, to improve clinical practice, healthcare management, and, finally, patients' quality of life.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1477227"},"PeriodicalIF":3.9,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560452/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between gas insufflation and gasless techniques for endoscopic transaxillary thyroidectomy. 内窥镜经腋窝甲状腺切除术中气体充气和无气技术的比较。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1434419
Li Lin, Shuxun Chen, Yizhuo Lu

Objective: This study aimed to compare clinical outcomes and prognosis of endoscopic thyroidectomy via axillary approach using insufflation and gasless methods.

Methods: Retrospective analysis included patients undergoing endoscopic thyroidectomy at our institution from June 2022 to October 2023. Patients were categorized into insufflation and gasless groups. Analysis compared surgical time, blood loss, drainage volume, tube removal time, hospital stay, complications, pain score, and incision satisfaction.

Results: 73 patients (48 insufflation, 25 gasless) were analyzed. Insufflation technique showed significantly superior outcomes: shorter surgery duration, reduced drainage volume, earlier tube removal, shorter hospital stay, and higher incision satisfaction (all P < 0.05). Postoperative pain (VAS) was lower in insufflation group on first day, but no significant difference on seventh day. No significant differences in blood loss or complications were observed.

Conclusion: Insufflation technique offers advantages over gasless method including shorter operation time, reduced drainage, earlier tube removal, and shorter hospital stays, with comparable outcomes in pain and incision satisfaction.

目的本研究旨在比较经腋窝入路采用充气法和无气法进行内镜下甲状腺切除术的临床效果和预后:回顾性分析包括2022年6月至2023年10月在我院接受内镜下甲状腺切除术的患者。患者分为充气组和无气组。分析比较了手术时间、失血量、引流量、拔管时间、住院时间、并发症、疼痛评分和切口满意度:分析了 73 名患者(充气组 48 人,无气组 25 人)。充气技术的效果明显优于无充气技术:手术时间更短、引流量更少、拔管时间更早、住院时间更短、切口满意度更高(所有数据均小于 0.05)。充气组术后第一天的疼痛(VAS)较轻,但第七天无明显差异。在失血量或并发症方面无明显差异:结论:与无气方法相比,充气技术具有手术时间短、引流量少、拔管时间早、住院时间短等优点,而且在疼痛和切口满意度方面效果相当。
{"title":"Comparison between gas insufflation and gasless techniques for endoscopic transaxillary thyroidectomy.","authors":"Li Lin, Shuxun Chen, Yizhuo Lu","doi":"10.3389/fendo.2024.1434419","DOIUrl":"10.3389/fendo.2024.1434419","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to compare clinical outcomes and prognosis of endoscopic thyroidectomy via axillary approach using insufflation and gasless methods.</p><p><strong>Methods: </strong>Retrospective analysis included patients undergoing endoscopic thyroidectomy at our institution from June 2022 to October 2023. Patients were categorized into insufflation and gasless groups. Analysis compared surgical time, blood loss, drainage volume, tube removal time, hospital stay, complications, pain score, and incision satisfaction.</p><p><strong>Results: </strong>73 patients (48 insufflation, 25 gasless) were analyzed. Insufflation technique showed significantly superior outcomes: shorter surgery duration, reduced drainage volume, earlier tube removal, shorter hospital stay, and higher incision satisfaction (all P < 0.05). Postoperative pain (VAS) was lower in insufflation group on first day, but no significant difference on seventh day. No significant differences in blood loss or complications were observed.</p><p><strong>Conclusion: </strong>Insufflation technique offers advantages over gasless method including shorter operation time, reduced drainage, earlier tube removal, and shorter hospital stays, with comparable outcomes in pain and incision satisfaction.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1434419"},"PeriodicalIF":3.9,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1